Anticoagulation for the intial treatment of venous thromboembolism in patients with cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anticoagulation for the Intial Treatment of Venous Thromboembolism in Patients With Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451933/all/images/ios-appstore-badge.png.
Anticoagulation for the intial treatment of venous thromboembolism in patients with cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451933/all/images/ios-appstore-badge.png. Accessed April 27, 2024.
Anticoagulation for the intial treatment of venous thromboembolism in patients with cancer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451933/all/images/ios-appstore-badge.png
Anticoagulation for the Intial Treatment of Venous Thromboembolism in Patients With Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451933/all/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anticoagulation for the intial treatment of venous thromboembolism in patients with cancer
ID - 451933
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451933/all/images/ios-appstore-badge.png
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -